Evercore ISI analyst Vijay Kumar raised the firm’s price target on Intuitive Surgical to $270 from $240 and keeps an In Line rating on the shares. Expectations were high, but Intuitive "managed to beat those expectations handily," with procedures growing about 26% in Q1, the analyst tells investors. Despite the strong Q1, "we are hard pressed to find upside" as the stock’s valuation causes Evercore to remain on sidelines, the analyst added.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ISRG:
- Intuitive Surgical price target raised to $285 from $265 at Morgan Stanley
- Intuitive Surgical price target raised to $325 from $300 at Truist
- Intuitive Surgical price target raised to $315 from $300 at BofA
- Intuitive Surgical price target raised to $300 from $250 at Mizuho
- Intuitive Surgical price target raised to $310 from $289 at Wells Fargo